Here's a Progress PR FYI make it a great day... Vancouver, BC, August 6, 2019 - INVICTUS MD STRATEGIES CORP. (IVITF) ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon, Chief Executive Officer of Invictus, is pleased to report that Acreage Pharms Ltd. (“Acreage”), the Company’s wholly owned subsidiary has substantially completed the construction of the 90,000 square foot Phase III cultivation facility in Edson, Alberta (the “Facility”). An amendment to Acreage’s license for the Phase III West wing was submitted to Health Canada on July 22, 2019. The amendment to the license is an expansion to the current license under the Cannabis Act, as the three facilities are on the same property. The west wing of the Facility has 45,000 square feet containing 20 flowering rooms, 3 drying rooms, processing rooms and propagation rooms. Each flowering room is 1,440 square feet, fitted with rolling tables to maximize canopy area and hydroponic growth. One flowering room is expected to be brought into production every four days to provide for ongoing harvesting and production of finished product. The west wing is expected to produce 105 harvests annually for a total production of approximately 5,000 kg per year. Total production of Phase I, Phase II and Phase III is expected to be approximately 7,500 kg per year. It is anticipated that the east wing of Phase III, which is identical to the west wing will be brought into production later in the year. https://ml.globenewswire.com/media/0261d5fd-5307-4957-b949-7d9d0e0597c3/medium/
Mr. Dixon states, “Acreage has the genetics and biomass ready to populate the west wing of Phase III as soon as the amended license is awarded. The west wing is expected to add to the Company’s annual income in addition to Phase I and II, which combined, currently produce 2,400 kg per year and have been in full production since early 2019.”
News 
Market Data 
Discover 
